Muscle-eye-brain disease: A neuropathological study

Annals of Neurology

Volumn 41, Issue 2, 1997, Pages 173-180

  Haltia, M ^a   Leivo, I ^a   Somer, H ^a   Pihko, H ^a   Paetau, A ^a   Kivela T ^a   Tarkkanen, A ^a   Tome F ^b   Engvall, E ^c   Santavuori, P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b CNRS   (France)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EYE DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUSCULAR DYSTROPHY; NEUROPATHOLOGY; PRIORITY JOURNAL; WALKER WARBURG SYNDROME;

ADULT; BRAIN DISEASES; CHILD; EYE DISEASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCULAR ATROPHY;

EID: 0031044984     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410208     Document Type: Article

References (46)

1. Warburg M. The heterogeneity of microphthalmia in the mentally retarded. Birth Defects 1971;7:136-154
2. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type-clinical, genetic and pathological considerations. Brain Dev 1981;3:1-29
3. Dambska M, Wisniewski K, Sher J, Solish G. Cerebro-oculo-muscular syndrome: a variant of Fukuyama congenital cerebro-muscular dystrophy. Clin Neuropathol 1982;1:93-98
4. Korinthenberg R, Pal D, Schlake W, Klein J. Congenital muscular dystrophy, brain malformation and ocular problems (muscle, eye and brain disease) in two German families. Eur J Pediatr 1984;142:64-68
5. Towfighi J, Sassani JW, Suzuki K, Ladda RL. Cerebro-ocular dysplasia-muscular dystrophy (COM-MD). Acta Neuropathol (Berl) 1984;65:110-123
6. Williams RS, Swishet CN, Jennings M, et al. Cerebro-ocular dysgenesis (Walker-Warburg syndrome): neuropathological and etiological analysis. Neurology 1984;34:1531-1541
7. Dobyns W, Kirkpatrick JB, Hittner HM, et al. Syndromes with lissencephaly II. Walker-Warburg and cerebro-oculo-muscular syndromes and a new syndrome with type II lissencephaly. Am J Med Genet 1985;22:157-195
8. Dobyns W, Pagon R, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 1989;32:195-210
9. Santavuori P, Leisti J, Kruus S. Muscle, eye and brain disease: a new syndrome. Neuropadiatrie 1977;8(suppl):553-558
10. Santavuori P, Somer H, Sainio K, et al. Muscle-eye-brain disease (MEB). Brain Dev 1989;11:147-153
11. Raitta C, Lamminen A, Santavuori P, Leisti J. Ophthalmological findings in a new syndrome with muscle, eye and brain involvement. Acta Ophthalmol 1978;56:465-472
12. Pihko H, Lappi M, Raitta C, et al. Ocular Endings in muscle eye-brain (MEB) disease: a follow-up study. Brain Dev 1995;17:57-61
13. Yoshioka M, Kuroki S, Kondo T. Ocular manifestations in Fukuyama type congenital muscular dystrophy. Brain Dev 1990;12:423-426
14. Dobyns WB, Truwit CL Lissencephaly and other malformations of cortical development: 1995 update. Neuropediatrics 1995;26:132-147
15. Ranta S, Pihko H, Santavuori P, et al. Muscle-eye-brain disease and Fukuyama type congenital muscular dystrophy are not allelic. Neuromusc Disord 1995;5:221-225
16. Hayashi YK, Engvall E, Arikawa-Hirasawa E, et al. Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sci 1993;119:53-64
17. Wever UM, Durkin ME, Zhang X, et al. Laminin β2 chain and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy). Neurology 1995;45:2099-2111
18. Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc Disord 1995;5:301-305
19. Sewry CA, Philpot J, Mahony D, et al. Expression of laminin subunits in congenital muscular dystrophy. Neuromusc Disord 1995;5:307-316
20. Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin α2 chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995;11:216-218
21. Engvall E, Davis GE, Dickerson K, et al. Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site. J Cell Biol 1986;103:2457-2465
22. Engvall E, Earwicker D, Haaparanta T, et al. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul 1990;1:731-740
23. Burgeson RE, Chiquet M, Deutzmann R, et al. A new nomenclature for the laminins. Matrix Biol 1994;14:209-211
24. Leivo I, Engvall E. Merosin, a protein specific for basement membrane of Schwann cells, striated muscle and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci USA 1988;85:1544-1548
25. Ehrig K, Leivo I, Argraves WS, et al. Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc Natl Acad Sci USA 1990;87:3264-3268
26. Khurana TS, Hoffman EP, Kunkel LM. Identification of a chromosome G-encoded dystrophin-related protein. J Biol Chem 1990;265:1617-1620
27. Sanes JR, Engvall E, Butkowski R, Hunter DD. Molecular heterogeneity of basal laminae: isoforms of laminin and type IV collagen at the neuromuscular junction and elsewhere. J Cell Biol 1990;111:1685-1699
28. Dubowitz V. Workshop report: 22nd ENMC sponsored workshop on congenital muscular dystrophy held in Baarn, The Netherlands, 14-16 May 1993. Neuromusc Disord 1994;4:75-81
29. Gershoni-Baruch R, Mandel H, Miller B, et al. Walker-Warburg syndrome with microtia and absent auditory canals. Am J Med Genet 1990;37:87-91
30. Wargowski DS, Chitayat D, Tyson RW, et al. Lethal congenital muscular dystrophy with cataracts and a minor brain anomaly: new entity or variant of Walker-Warburg syndrome? Am J Med Genet 1991;39:19-24
31. Yoshioka M, Kuroki S, Niagmi H, et al. Clinical variation within sibships in Fukuyama-type congenital muscular dystrophy. Brain Dev 1992;14:334-347
32. Toda T, Yoshioka M, Nakahori Y, et al. Genetic identity of Fukuyama-rype congenital muscular dystrophy and Walker-Warburg syndrome. Ann Neurol 1995;37:99-101
33. Toda T, Segawa M, Nomura Y, et al. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nat Genet 1994;7:113
34. Valanne L, Pihko H, Katevuo K, et al. MRI of the brain in muscle-eye-brain (MEB) disease. Neuroradiology 1994;36:473-476
35. Takada K, Nakamura H, Tanaka Y. Cortical dysplasia in congenital muscular dystrophy with central nervous system involvement (Fukuyama type). J Neuropathol Exp Neurol 1984;43:395-407
36. Warburg M. Ocular malformations and lissencephaly. Eur J Pediatr 1987;146:450-452
37. Chijiiwa T, Nishimura M, Inomata H, et al. Ocular manifestations of congenital muscular dystrophy (Fukuyama type). Ann Ophthalmol 1983;15:921-928
38. Campbell KP. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 1995;80:675-679
39. Engel J. Structure and function of laminin. In: Rohrbach DH, Timpl R, eds. Molecular and cellular aspects of basement membranes. San Diego: Academic Press, 1993:147-171
40. Vuolteenaho R, Nissinen M, Sainio K, et al. Human laminin M chain (merosin): complete primary structure, chromosomal assignment and expression of the M and A chains in human fetal tissues. J Cell Biol 1994;124:381-394
41. Tome FMS, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency, CR Acad Sci [III] 1994;317:351-357
42. Voit T, Sewry CA, Meyer K, et al. Preserved merosin M-chain (or laminin α2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin deficient congenital muscular dystrophy. Neuropediatrics 1995;26:148-155
43. Bönnemann CG, Modi R, Noguchi S, et al. β-Sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995;11:266-273
44. Takada K, Nakamura H, Suzumori K, et al. Cortical dysplasia in a 23-week fetus with Fukuyama congenital muscular dystrophy (FCMD). Acta Neuropathol 1987;74:300-306
45. Calof AL, Lander AD. Relationship between neuronal migration and cell-substratum adhesion: laminin and merosin promote olfactory neuronal migration but are anti-adhesive. J Cell Biol 1991;115:779-794
46. Engwall E, Earwicker D, Day A, et al. Merosin promotes cell attachment and neurite outgrowth and is a component of the neurite promoting factor of RN22 schwannoma cells. Exp Cell Res 1992;198:115-123